Login / Signup

Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study

Huijuan WangHuixing ZhouZhiyao ZhangChuanying GengWenming Chen
Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)
It was found that BBRs could significantly improve OS for both pPCL and sPCL patients.
Keyphrases
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • acute myeloid leukemia
  • single cell
  • prognostic factors
  • mesenchymal stem cells